两性霉素B、咪康唑和酮康唑对人粒细胞祖细胞的体外毒性。
Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro.
作者信息
Meeker T C, Siegel M S, Shiota F M, Crowley J J, McGuffin R W
出版信息
Antimicrob Agents Chemother. 1983 Jan;23(1):169-71. doi: 10.1128/AAC.23.1.169.
Abstract
Granulocyte progenitor cells were grown in culture with amphotericin B, miconazole, and ketoconazole. Significant suppression of progenitor cell growth could be demonstrated with all three drugs at increasing concentrations. No additive suppression was seen when amphotericin B and ketoconazole were combined.
摘要
粒细胞祖细胞在含有两性霉素B、咪康唑和酮康唑的培养基中培养。随着三种药物浓度的增加，均可证明祖细胞生长受到显著抑制。当两性霉素B和酮康唑联合使用时，未见相加抑制作用。
相似文献
1
Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro.两性霉素B、咪康唑和酮康唑对人粒细胞祖细胞的体外毒性。
Antimicrob Agents Chemother. 1983 Jan;23(1):169-71. doi: 10.1128/AAC.23.1.169.
2
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.氟康唑及其他唑类抗真菌药物对小鼠和人粒细胞-巨噬细胞祖细胞体外毒性的比较。
J Antimicrob Chemother. 1999 May;43(5):675-81. doi: 10.1093/jac/43.5.675.
3
Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function.酮康唑、两性霉素B及两性霉素B甲酯：对中性粒细胞功能的体外及体内毒理学效应比较
Antimicrob Agents Chemother. 1981 Nov;20(5):660-5. doi: 10.1128/AAC.20.5.660.
4
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.两性霉素B、5-氟胞嘧啶、酮康唑和咪康唑在体外对致病真菌的相互作用。
Antimicrob Agents Chemother. 1982 Nov;22(5):763-70. doi: 10.1128/AAC.22.5.763.
5
Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.接合菌对两性霉素B、咪康唑和酮康唑的敏感性。
Antimicrob Agents Chemother. 1981 Nov;20(5):688-90. doi: 10.1128/AAC.20.5.688.
6
In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice.抗真菌剂对小鼠造血细胞作用的体外和体内研究。
Exp Biol Med (Maywood). 2015 Dec;240(12):1728-34. doi: 10.1177/1535370215590820. Epub 2015 Jun 16.
7
Antifungal agents used in systemic mycoses. Activity and therapeutic use.用于全身性真菌病的抗真菌药物。活性与治疗用途。
Drugs. 1983 Jan;25(1):41-62. doi: 10.2165/00003495-198325010-00003.
8
9
Ocular toxicity of topical antifungal agents.
Arch Ophthalmol. 1981 Jun;99(6):1081-4. doi: 10.1001/archopht.1981.03930011081019.
10
Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.皮肤真菌对两性霉素B、咪康唑、酮康唑、氟胞嘧啶和利福平单独及联合使用的敏感性。
Sabouraudia. 1982 Jun;20(2):109-13. doi: 10.1080/00362178285380181.
引用本文的文献
1
Comparison of ketoconazole and amphotericin B in interference with thymidine uptake by and blastogenesis of lymphocytes stimulated with Histoplasma capsulatum antigens.
Antimicrob Agents Chemother. 1983 Oct;24(4):575-8. doi: 10.1128/AAC.24.4.575.
2
Adverse drug reactions to systemic antifungals. Prevention and management.全身性抗真菌药物的药物不良反应。预防与管理。
Drug Saf. 1992 Sep-Oct;7(5):323-63. doi: 10.2165/00002018-199207050-00003.
本文引用的文献
1
Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro.阿昔洛韦在体外对粒细胞祖细胞无毒性。
Antimicrob Agents Chemother. 1980 Sep;18(3):471-3. doi: 10.1128/AAC.18.3.471.
2
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.针对长期发热且粒细胞减少的癌症患者的经验性抗生素和抗真菌治疗。
Am J Med. 1982 Jan;72(1):101-11. doi: 10.1016/0002-9343(82)90594-0.
3
Strategies in the treatment of systemic fungal infections.系统性真菌感染的治疗策略。
N Engl J Med. 1980 Jan 17;302(3):145-55. doi: 10.1056/NEJM198001173020304.
4
Amphotericin-B-induced thrombocytopenia.
Ann Intern Med. 1982 Mar;96(3):332-3. doi: 10.7326/0003-4819-96-3-332.
5
Disposition of ketoconazole, an oral antifungal, in humans.酮康唑（一种口服抗真菌药）在人体内的处置。
Antimicrob Agents Chemother. 1982 Jan;21(1):151-8. doi: 10.1128/AAC.21.1.151.
6
Ketoconazole for treatment of disseminated coccidioidomycosis.
Ann Intern Med. 1982 Apr;96(4):436-40. doi: 10.7326/0003-4819-96-4-436.
7
Ketoconazole: a major innovation for treatment of fungal disease.酮康唑：治疗真菌病的一项重大创新。
Ann Intern Med. 1980 Dec;93(6):921-3. doi: 10.7326/0003-4819-93-6-921.
8
Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.两性霉素B与酮康唑联合治疗实验性组织胞浆菌病和隐球菌病
Rev Infect Dis. 1980 Jul-Aug;2(4):551-58. doi: 10.1093/clinids/2.4.551.
9
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.
Lancet. 1982 Apr 10;1(8276):826-9. doi: 10.1016/s0140-6736(82)91874-8.
10
A pharmacologic guide to the clinical use of amphotericin B.两性霉素B临床应用的药理学指南
J Infect Dis. 1969 Oct;120(4):427-36. doi: 10.1093/infdis/120.4.427.
Zotero 插件